We know what is going on. It is a single product company in the midst of an approval, now with multiple new potential trials and drugs because of the recent deal they made with a top cancer center in their field, a major vote of confidence.
They have a licensed manufacturing facility and are allowed to provide the product on a compassionate basis after a successful phase 3 and they have stunning results from that trial and a secondary combination trial in major journals, JAMA Oncology and Nature, both peer reviewed.
What exactly do you have. You still can’t tell us all of it, just your fake hints.
I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.
